Table 3.
Variable | AFP-L3 (%) | ||
---|---|---|---|
<10 (n=85) | =10(n=80) | Total | |
Total AFP 10-200 (ng/ml) | |||
Number of Subjects | 15 | 37 | 52 |
Observed Deaths | 6 | 17 | 23 |
Expected Deaths | 10.44 | 21.03 | 31.48 |
O/E ratio (95% CI) | 0.57 (0.21-1.25) | 0.81 (0.47-1.29) | 0.73 (0.46-1.10) |
Total AFP >200 (ng/ml) | |||
Number of Subjects | 8 | 43 | 51 |
Observed Deaths | 6 | 36 | 42 |
Expected Deaths | 3.01 | 17.10 | 20.11 |
O/E ratio (95% CI) | 1.99 (0.73-4.33) | 2.11 (1.47-2.91) | 2.09 (1.50-2.82) |
All HCC with AFP =10 (ng/ml) | |||
Number of Subjects | 23 | 80 | 103 |
Observed Deaths | 12 | 53 | 65 |
Expected Deaths | 13.46 | 38.13 | 51.59 |
O/E ratio† (95% CI) | 0.89 (0.46-1.56) | 1.39 (1.04-1.82) | 2.28 (0.97-1.61) |
| |||
Expected Deaths Adj. AFP | 13.74 | 51.26 | |
O/E ratio (95% CI) | 0.9 (0.45-1.53) | 1 (0.77-1.35) |
* Expected deaths estimated from the number of deaths during follow-up
The model chi squares for the analyses stratified by total AFP were not significant, thus the analyses performed were for the combined AFP groups
O/E observed/expected ratio.